slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Venture Investment Bank for Early Stage Technology Companies We Invest Through: PowerPoint Presentation
Download Presentation
Venture Investment Bank for Early Stage Technology Companies We Invest Through:

Loading in 2 Seconds...

play fullscreen
1 / 23

Venture Investment Bank for Early Stage Technology Companies We Invest Through: - PowerPoint PPT Presentation


  • 105 Views
  • Uploaded on

Who We Are. Venture Investment Bank for Early Stage Technology Companies We Invest Through: Angel & Institutional Investor Members Capital Managed Internally NASD\Broker Dealer. The Fact is……. VCs Don’t Invest in Early Stage Companies Angels Do!. Early Stage.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Venture Investment Bank for Early Stage Technology Companies We Invest Through:' - frisco


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide2

Who We Are

  • Venture Investment Bank for Early Stage Technology Companies
  • We Invest Through:
    • Angel & Institutional Investor Members
    • Capital Managed Internally
  • NASD\Broker Dealer
slide3

The Fact is……

VCs Don’t Invest in Early Stage Companies

Angels Do!

slide4

Early Stage

Seed ‘A’ Round ‘B+’ Rounds Mezzanine IPO/Exit

Capital Chasm

$200k $.5 – $5M $10M+ $10 - $30M $40M+

slide5

Ten Highly Effective Habits of

Successful Angel Investing

1. Get out 20 Envelopes

slide6

Ten Highly Effective Habits of

Successful Angel Investing

2. Be Quick but don’t Hurry

slide7

Ten Highly Effective Habits of

Successful Angel Investing

3. Invest in Deals you Understand

slide8

Ten Highly Effective Habits of

Successful Angel Investing

4. Don’t try to change the Company

slide9

Ten Highly Effective Habits of

Successful Angel Investing

5. Do your own Competitive Analysis Research

slide10

Ten Highly Effective Habits of

Successful Angel Investing

6. Get to KNOW the Customer

slide11

Ten Highly Effective Habits of

Successful Angel Investing

7. Really get to KNOW the Team

slide12

Ten Highly Effective Habits of

Successful Angel Investing

8. Never, ever Fall in Love

slide13

Ten Highly Effective Habits of

Successful Angel Investing

9. Know the Intellectual Property

slide14

Ten Highly Effective Habits of

Successful Angel Investing

10. Know who you pass the Baton to – before you invest

slide15
Our Value Proposition

is

Superior Deal Selection

&

Superior Deal Support

slide16

Deal Selection Process

  • Initial Screening by Angel Capital Staff
  • Qualified Deals go to Expert Angel

Members for Analysis

  • Engage VCs in Due Diligence Review
  • Engage Relevant Strategic Investors
slide17

Deal Selection Criteria

  • Angel Investors with Deep Relevant Industry Experience Willing to:
    • Invest
    • Serve as Advisors
  • VCs Willing to Fund Later Rounds Based on Certain Milestones
  • Defensible IP
slide18

Deal Support

  • Introduce:
    • Expert Angels Who Invest and Join Board
    • Industry Board Members
    • Strategic Relationships
    • VCs with Relevant Expertise
  • Valuation and Deal Structure
  • Ongoing Corporate Finance Services
slide19
Disruptive Technology in Intelligent Storage Networks
  • 12 patents filed, more to come
  • Market projected to grow 900% by 2003 to $6.7B
  • Experienced management team has built two successful companies
  • Elite industry board
  • Key industry relationships in place
slide20

BioRight International, Inc.

  • Breakthrough Nonprescription Cold
  • & Allergy Medicines
    • Launched 11/00 - Sales Exceeding $1.3 Million
    • Distribution in Over 22,000 Retail Pharmacies – Walgreens, Rite-Aid, Eckerds, Safeway, Osco, Longs
    • Pipeline for New Product Introductions
    • Revenue Growth to Over $100 Million Within 5 Years
    • Management Combines Medical Expertise With 25 Year Track Record of Retail Product Introductions
slide21
Multifocal Contact Lens With Strong Patents and High Consumer Demand
  • Clinical Data Consistently Outperforms Any Lens on the Market (Including J&J Acuvue)
  • FDA Approval Received for:
    • Custom (Lathed Lens) Launched in US and Canada
    • Cast Molded Lens (Disposable & Mass Produced)
  • CE Mark Received for Astigmatic Intraocular Lens
slide22

Contact Information

  • Mike Pogue - President
    • (415) 289-4618
    • mpogue@angelcapitalnetwork.com